In vascular retinal diseases like diabetic retinopathy and vein occlusion, however, intravitreal application would be a suitable treatment method as anti-VEGF agents need to be injected anyway, and a local treatment is desired. This evidence concerns the gene VEGFA and diabetic retinopathy.